

Translational goals are to develop and deliver comprehensive evidence-based strategies to achieve a measurable lasting reduction in the cancer burden, especially among the underserved.Ĭancer is the singular focus for MD Anderson’s workforce of more than 19,000 employees with over 1,600 full-time faculty scholars who lead the largest number of NCI-funded grant programs and clinical trials of any institution in the nation. MD Anderson houses one of the largest, most developed cancer prevention programs in the nation, conducting research to assess and manage cancer risk through early detection, genetic counseling and clinical interventions, and implementing prevention programs that include genetic testing, chemoprevention, behavioral and nutritional counseling. MD Anderson’s strength lies in its ability to rapidly translate scientific knowledge into improved cancer therapies and prevention strategies. In 1971 MD Anderson became one of the nation’s first NCI-designated comprehensive cancer centers. Mission areas include patient care, research, education, and prevention. The University of Texas MD Anderson Cancer Center (MD Anderson) was established by the Texas State Legislature in 1941and is a free-standing, degree-granting health institution within The University of Texas System.
